Advances in deep brain stimulation could lead to new treatments
(Wyss Center for Bio and Neuroengineering) A new paper published in Nature Reviews Neurology suggests that recent advances in deep brain stimulation (DBS) for Parkinson disease could lead to treatments for conditions such as obsessive-compulsive disorder (OCD), Gilles de la Tourette syndrome and depression. The authors of the paper argue that bi-directional electrodes which can both stimulate and record from deep brain structures -- known as closed-loop DBS -- could have applications beyond Parkinson disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 8, 2019 Category: International Medicine & Public Health Source Type: news

Deep Brain Stimulation: Remote Control Brain
We have the story of one woman who is taking part in an experiment on deep brain stimulation. (Source: NPR Health and Science)
Source: NPR Health and Science - March 29, 2019 Category: Consumer Health News Authors: Alix Spiegel Source Type: news

Seizure Freedom in TLE Tied to Piriform Cortex Resection Seizure Freedom in TLE Tied to Piriform Cortex Resection
Results from a study of individuals with temporal lobe epilepsy (TLE) who underwent surgery could have important implications in terms of a target for drug development and deep brain stimulation.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 21, 2019 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

Deep brain stimulation provides sustained relief for severe depression
(University of Freiburg) Patients suffering from severe, treatment-resistant depression can benefit not only acutely but also the long-term from deep brain stimulation, as researchers from the Medical Center -- University of Freiburg and their colleagues from the University Hospital Bonn demonstrate in a current study. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 19, 2019 Category: International Medicine & Public Health Source Type: news

Surgeon performs 'world first' remote brain surgery on patient 1,800 MILES AWAY
A surgeon in China has allegedly used computers to put a deep brain stimulation implant into a patient in Beijing while he was in the city of Sanya, on an island more than 1,800 miles to the south. (Source: the Mail online | Health)
Source: the Mail online | Health - March 18, 2019 Category: Consumer Health News Source Type: news

MRC-funded study suggests deep brain stimulation could help OCD symptoms
The debilitating behaviours and all-consuming thoughts, which affect people with severe obsessive compulsive disorder (OCD), could be significantly improved with targeted deep brain stimulation, according to the findings of an MRC-funded study. (Source: Medical Research Council General News)
Source: Medical Research Council General News - March 9, 2019 Category: Research Source Type: news

Patients with severe OCD undergo deep brain stimulation trial
Scientists say procedure showed improvements but larger clinical experiment needed to confirm benefitsPatients with severeobsessive-compulsivedisorder have shown remarkable improvements after undergoing an experimental procedure in which electrodes are placed inside the brain.The first UK trial of deep brain stimulation for OCD involved six people who were extremely severely affected by the condition. The patients each had four electrodes surgically inserted through the skull into the brain. These are used to electrically stimulate brain circuits with the aim of bringing the illness under control.Continue reading... (Sourc...
Source: Guardian Unlimited Science - March 8, 2019 Category: Science Authors: Hannah Devlin Science correspondent Tags: Obsessive-compulsive disorder Science Health Mental health Society UK news Source Type: news

Deep brain stimulation sites for OCD target distinct symptoms
(Elsevier) Deep brain stimulation (DBS) reduces symptoms of severe obsessive-compulsive disorder (OCD) during stimulation of either the ventral capsule (VC) or anteromedial subthalamic nucleus (amSTN), according to a study in Biological Psychiatry. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 7, 2019 Category: International Medicine & Public Health Source Type: news

Wake Forest Baptist receives NIH grant to study deep brain stimulation for Alzheimer's
(Wake Forest Baptist Medical Center) Scientists at Wake Forest Baptist Health have been awarded $3.9 million from the National Institutes of Health to determine if a procedure used to treat Parkinson's patients can improve age-related cognitive abilities and counteract the effects of Alzheimer's and other types of dementia. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 6, 2019 Category: International Medicine & Public Health Source Type: news

Benefit of DBS for Essential Tremor Fades Over Time Benefit of DBS for Essential Tremor Fades Over Time
Deep brain stimulation can be an effective treatment for severe refractory essential tremor but new research suggests its benefits fade over time.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 5, 2019 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

Report: Medtronic to close Portsmouth, N.H. transformative solutions facility
Medtronic (NYSE:MDT) said this week that it plans to close its Portsmouth, N.H.-based transformative solutions facility within the year, according to a Portsmouth Herald report. The Fridley, Minn.-based company recently informed employees at the facilities that it planned to eliminate its Portsmouth jobs, according to the report. The facilities currently employ 150 individuals. Medtronic spokesperson Brett Cromwell said that the transformative solutions division had announced changes “being made to help focus the business and strengthen its financial position,” according to the Portsmouth Herald. &ldq...
Source: Mass Device - February 21, 2019 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Featured Medtronic Source Type: news

Choice of Anesthesia Technique for Deep Brain Stimulation Choice of Anesthesia Technique for Deep Brain Stimulation
The authors present their experiences with an alternative anesthesia technique for deep brain stimulation surgery for Parkinson's disease patients who cannot tolerate conscious sedation.BMC Anesthesiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 21, 2019 Category: Consumer Health News Tags: Anesthesiology Journal Article Source Type: news

Medtronic launches DBS for medically-refractory epilepsy in the U.S.
Medtronic (NYSE:MDT) said today that it launched its Deep Brain Stimulation system intended for medically-refractory epilepsy in the U.S. The Fridley, Minn.-based company said that the first patient was implanted with the system at Atlanta’s Emory University. “At Medtronic, we have a long-standing commitment to helping patients with medically refractory epilepsy through DBS, and we continue to explore other treatments and solutions along the epilepsy treatment pathway. With the FDA approval, commercial launch, and policy updates from several health insurers, we are positioned to help more people than ever ...
Source: Mass Device - February 20, 2019 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Featured Neuromodulation/Neurostimulation Medtronic Source Type: news

Clinical and anatomical predictors for freezing of gait and falls after subthalamic deep brain stimulation in Parkinson's disease patients - Karachi C, Cormier-Dequaire F, Grabli D, Lau B, Belaid H, Navarro S, Vidailhet M, Bardinet E, Fernandez-Vidal S, Welter ML.
INTRODUCTION: Freezing of gait (FOG) and falls are the most disabling motor symptoms in Parkinson's disease (PD) patients. The effects of subthalamic deep-brain-stimulation (STN-DBS) on FOG and falls are still a matter of controversy, and factors contribut... (Source: SafetyLit)
Source: SafetyLit - February 4, 2019 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Functional Neuromodulation Announces CEO Leadership Transition
Todd Langevin named CEO MINNEAPOLIS, Jan. 25, 2019 -- (Healthcare Sales & Marketing Network) -- Functional Neuromodulation Ltd. ("FNM" or the "Company"), a medical device company focused on bringing to market DBS-f, an implantable d... Devices, Neurology, Personnel Functional Neuromodulation, DBS-f, deep brain stimulation, Alzheimer's disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 25, 2019 Category: Pharmaceuticals Source Type: news

Treatment of Parkinson's disease: Separating hope from hype
(Bentham Science Publishers) This review emphasized the development of various non-pharmaceutical therapeutic approaches and mainly highlighted the cutting-edge treatments for PD including gene- and stem cell-based therapies, targeted delivery of neurotrophic factors, and brain stimulation techniques such as Transcranial Magnetic Stimulation (TMS), transcranial Direct Current Stimulation (tDCS), and Deep Brain Stimulation (DBS). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 26, 2018 Category: International Medicine & Public Health Source Type: news

An Ethical Framework for Deep Brain Stimulation in Children An Ethical Framework for Deep Brain Stimulation in Children
While deep brain stimulation may be effective for the treatment of refractory neurodevelopmental conditions in children, it poses unique ethical, social, and legal challenges.Neurosurgical Focus (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 19, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news

Operating Rooms Get a Dose of Augmented Reality
Operating rooms are set to get a dose of augmented reality because of a new clearance from FDA. The agency recently signed off on an augmented surgical navigation system from Mariner Endosurgery. The Ontario-based company’s LaparoGuard is an augmented surgical navigation system that enables surgeons to annotate areas of 3D safety zones during minimally invasive procedures, to aid surgeons in guiding their tools and informing their surgical approach. Similar to the heads-up display of a fighter jet, LaparoGuard allows surgeons to annotate areas of risk, and then see 3D renderings of surgeon-defined safety ...
Source: MDDI - December 15, 2018 Category: Medical Devices Authors: Omar Ford Tags: Regulatory and Compliance Imaging Source Type: news

First child in Canada undergoes deep brain stimulation for epilepsy, hospital says
A 9-year-old girl is the first child in Canada to undergo deep brain stimulation for epilepsy after years of suffering up to 150 seizures a day. (Source: CBC | Health)
Source: CBC | Health - December 13, 2018 Category: Consumer Health News Tags: News/Canada/Toronto Source Type: news

FDA chooses 8 medtech companies for opioid crisis challenge
(Image from Unsplash.com) The FDA has selected eight medtech companies to develop devices to help reduce the country’s opioid abuse crisis. More than 250 companies submitted entries to the FDA Innovation Challenge: Devices to Prevent and Treat Opioid Use Disorder, announced in May. Those selected include Masimo Corp. and deep-brain-stimulation company Brainsway Ltd. The companies will be expected to produce devices intended to predict the risk of opioid used disorder (OUD), detect opioid overdose, dispense medication and provide pain treatment alternatives to opioids. (Source: FDA) The selected firms will work c...
Source: Mass Device - December 3, 2018 Category: Medical Devices Authors: Nancy Crotti Tags: Blog Food & Drug Administration (FDA) Implants Pain Management Research & Development algometRx Avanos Medical (formerly Halyard Health) Brainsway cognifisense ipill Masimo milliman ThermoTek Source Type: news

Deep Brain Stimulation of Orbitofrontal Cortex Relieves Depression
The result of a study among patients with epilepsy strengthens the case for the importance of this brain region in determining mood. (Source: The Scientist)
Source: The Scientist - December 3, 2018 Category: Science Tags: News & Opinion Source Type: news

Mayo Clinic Q and A: Deep brain stimulation may reduce seizures caused by epilepsy
DEAR MAYO CLINIC: How does deep brain stimulation for epilepsy work? Who?s a good candidate for this treatment? Is it effective? ANSWER:?Deep brain stimulation is a technique that uses a wire placed permanently in the brain to send electrical pulses to the brain. It has been approved by the Food and Drug Administration to treat [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - November 27, 2018 Category: Databases & Libraries Source Type: news

DBS Benefit in Alzheimer's May Only Extend to Older Patients DBS Benefit in Alzheimer's May Only Extend to Older Patients
Preliminary results suggest that deep brain stimulation (DBS) of the fornix is safe to use for 2 years and that it may have long-term benefit in patients with AD, but only in those older than 65 years.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 23, 2018 Category: Consumer Health News Tags: Psychiatry News Source Type: news

Panel Sheds Light on DBS Electrode Design Concerns
Traditionally there has always been a great deal of conversation surrounding deep brain stimulation (DBS) systems. However, this just hasn’t been the case for one of the most important components of the technology – the electrode. A panel at MD&M Minneapolis, being moderated by Eric Sabelman, a Neurosurgery Bioengineer at Kaiser Permanente, could help change the conversation and put the focus on electrodes. The panel is titled Deep Brain Stimulation: How Will New Electrodes Improve Results? “The particular reason I think for having a panel, is the electrode itself ...
Source: MDDI - October 4, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news

DBS for Seizure Control in Drug-resistant Epilepsy DBS for Seizure Control in Drug-resistant Epilepsy
This paper explores the use of deep brain stimulation as a promising treatment modality for decreasing seizure frequency in patients with refractory epilepsy.Neurosurgical Focus (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 21, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news

$20 million gift focuses UCSF on depression, mood disorders
A $20 million gift from a longtime UCSF benefactor will help researchers zero in on brain circuitry that sets off mood disorders, such as depression and anxiety, and target personalized treatments. The donation — the second gift of this size from the Ray and Dagmar Dolby Family Fund — will establish the UCSF Dolby Center for Mood Disorders to identify brain-imaging biomarkers that could be targeted for individualized deep-brain stimulation or other treatments. What’s more, the money w ill… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - September 18, 2018 Category: American Health Authors: Ron Leuty Source Type: news

Toward Adaptive Deep Brain Stimulation for Dystonia Toward Adaptive Deep Brain Stimulation for Dystonia
Can neural oscillations serve as potential biomarkers that might be used as feedback signals for controlling adaptive deep brain stimulation in patients with dystonia?Neurosurgical Focus (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 14, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news

Depression Treatment: Where We Are Missing the Mark
Depression affects 450 million people worldwide and 15 million adults in the United States (U.S.) alone. Suicide is the 10th leading cause of death in the United States, claiming over 40,000 lives every year. We see these heartbreaking stories making headlines too often, and there are tens of thousands more we do not know about. The scariest part? There is no end in sight. Antidepressants are one of the three most commonly used therapeutic drug classes in the United States. Approximately 1 in 9 Americans of all ages reported taking at least one antidepressant medication — a number that was less than 1 in 50 just th...
Source: Psych Central - September 7, 2018 Category: Psychiatry Authors: Sachin Mehta, M.D. Tags: Antidepressants Bipolar Depression Medications Mood Stabilizers Neuroscience Suicide Treatment Deep brain stimulation Deep transcranial magnetic stimulation Depression Treatment Electroconvulsive Therapy Major Depressive Disorder Source Type: news

Approaches to Closed-loop DBS for Movement Disorders Approaches to Closed-loop DBS for Movement Disorders
This paper summarizes investigational approaches to closed-loop systems of deep brain stimulation for treatment of movement disorders. Which approaches hold most promise?Neurosurgical Focus (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 7, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news

Deep brain stimulation for the treatment of disorders of consciousness and cognition in traumatic brain injury patients: a review - Kundu B, Brock AA, Englot DJ, Butson CR, Rolston JD.
Traumatic brain injury (TBI) is a looming epidemic, growing most rapidly in the elderly population. Some of the most devastating sequelae of TBI are related to depressed levels of consciousness (e.g., coma, minimally conscious state) or deficits in executi... (Source: SafetyLit)
Source: SafetyLit - August 3, 2018 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Abbott wins FDA MR-conditional labeling for Infinity DBS
Abbott (NYSE:ABT) said today it won expanded FDA approval for magnetic resonance conditional labeling for its Infinity Deep Brain Stimulation system designed to treat individuals with Parkinson’s disease and essential tremors. The update will be delivered through an over-the-air software upgrade to all currently implanted Infinity DBS systems, the company said. Abbott touted that with the approval, the Infinity DBS is the first and only FDA-approved MR-conditional directional DBS system. “With this software upgrade, Abbott delivers on a promise to develop powerful features that strengthen the Infinity...
Source: Mass Device - August 2, 2018 Category: Medical Devices Authors: Fink Densford Tags: Food & Drug Administration (FDA) Neurological Neuromodulation/Neurostimulation Regulatory/Compliance Abbott Source Type: news

Abbott Expands its Directional Deep Brain Stimulation Therapy by Offering New MR-Conditional Labeling
- FDA approval of new software upgrade for Abbott's deep brain stimulation therapy enables advanced, patient-centric features for people living with Parkinson's disease and essential tremor (Source: Abbott.com)
Source: Abbott.com - August 2, 2018 Category: Pharmaceuticals Source Type: news

High-Tech Parkinson's Therapy With A Powerful Consumer Touch
Smartphone technology combined with deep brain stimulation may offer a life-changing option for people with Parkinson's Disease. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - July 27, 2018 Category: Pharmaceuticals Authors: John Nosta, Contributor Source Type: news

Is Abbott Losing Share in Key Medtech Markets?
By and large, Abbott Laboratories had a phenomenal second quarter this year – and investors took notice. The company's stock hit its highest point since 1995 on Wednesday after beating Wall Street's quarterly expectations and raising its own outlook for 2018. Abbott, MD+DI's 2017 Medtech Company of the Year, clearly has a lot to celebrate as it continues to show the world what its made of. But at least one medtech analyst noticed that the company appears to have lost market share in cardiac rhythm management (CRM) and neuromodulation. Abbott reported CRM sales of $543 million in the second quarter, representing ...
Source: MDDI - July 18, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Cardiovascular Source Type: news

Medical News Today: Deep brain stimulation 'slows Parkinson's progression'
A recently published study finds that deep brain stimulation, used in early-stage Parkinson's disease, could slow the progression of tremor. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 30, 2018 Category: Consumer Health News Tags: Parkinson's Disease Source Type: news

Deep brain stimulation 'slows Parkinson's progression'
A recently published study finds that deep brain stimulation, used in early-stage Parkinson's disease, could slow the progression of tremor. (Source: Parkinson's Disease News From Medical News Today)
Source: Parkinson's Disease News From Medical News Today - June 30, 2018 Category: Neurology Tags: Parkinson's Disease Source Type: news

DBS treatment may slow the progression of Parkinson's tremor in early-stage patients
(Vanderbilt University Medical Center) Deep brain stimulation (DBS) may slow the progression of tremor for early-stage Parkinson's disease patients, according to a Vanderbilt University Medical Center study released in the June 29 online issue of Neurology ® , the medical journal of the American Academy of Neurology. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 29, 2018 Category: International Medicine & Public Health Source Type: news

UCLA global health program aims to boost neurological care in South Africa
When it came to getting the best treatment for his parents ’ neurologic illnesses, Sam Miller and his family experienced frustration finding the right doctors in their home country of South Africa.Miller ’s mother, Brenda, developed multiple sclerosis in her late 20s, and his father, Winston, was diagnosed with Parkinson’s disease in his 60s.Over the four decades of his mother ’s illness before her death in 2008, the increasingly acute shortage of neurologists in South Africa made the top specialists there much sought-after and overworked. They had little time to talk through treatment options, much...
Source: UCLA Newsroom: Health Sciences - June 26, 2018 Category: Universities & Medical Training Source Type: news

Medtronic wins expanded FDA indications for Kyphon HV-R bone cement
Medtronic (NYSE:MDT) said yesterday it won expanded FDA 510(k) clearance for its Kyphon HV-R bone cement designed for the fixation of pathological fractures of the sacral vertebral body. The Fridley, Minn.-based company’s Kyphon HV-R bone cement is now indicated for treating pathological fractures of the vertebral body due to osteoporosis, cancer or benign lesions using a cementoplasty procedure. The cement is also indicated for the fixation of pathological fractures of the sacral vertebral body or ala using sacral vertebroplasty or sacroplasty, the company said. “Patients who experience sacral insuff...
Source: Mass Device - June 21, 2018 Category: Medical Devices Authors: Fink Densford Tags: 510(k) Orthopedics Regulatory/Compliance Spinal Medtronic Source Type: news

Long-term DBS Linked to Less Psychosis, Falls in Parkinson's Long-term DBS Linked to Less Psychosis, Falls in Parkinson's
Ten-year follow-up of patients with Parkinson's disease who underwent subthalamic deep-brain stimulation (DBS) shows they had lower risk for psychosis and falls than those not receiving DBS.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 21, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Deep brain stimulation promising for mild Alzheimer's patients older than 65
Alzheimer's patients older than 65 benefit the most benefit from deep brain stimulation, according to findings from a recent phase II clinical trial. (Source: Health News - UPI.com)
Source: Health News - UPI.com - June 19, 2018 Category: Consumer Health News Source Type: news

Deep Brain Stimulation showing promise for patients with mild Alzheimer's disease over 65
(University Health Network) An age group analysis of data from the ADvance trial has shown that participants over the age of 65 continue to derive the most benefit from Deep Brain Stimulation of the fornix (DBS-f), as observed in the data from the phase 2 findings (12 - 24 months) of the Phase II trial. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 19, 2018 Category: International Medicine & Public Health Source Type: news

Medtronic's deep brain stimulation programmer and app get the FDA nod
Medical tech company Medtronic has just landed FDA clearance on its Deep Brain Stimulation (DBS) Clinical Programmer and ActivaProgramming application. (Source: mobihealthnews)
Source: mobihealthnews - June 18, 2018 Category: Information Technology Source Type: news

Medtronic wins FDA nod for DBS clinician programmer
Medtronic (NYSE:MDT) said today it won FDA approval for its Deep Brain Stimulation clinician programmer and Activa programming application. The Fridley, Minn.-based medtech giant said that the Activa programming application, which is designed for use with Samsung Galaxy Tab S2 tablets, is intended to streamline workflows and improve clinician programming for its Activa DBS system. Medtronic said that the programmer will enable upgrades to Activa rechargeable implantable neurostims that will extend their lifespans to 15 years, giving patients an additional six years before they need device replacement. The newly c...
Source: Mass Device - June 13, 2018 Category: Medical Devices Authors: Fink Densford Tags: Food & Drug Administration (FDA) Neurological Neuromodulation/Neurostimulation Regulatory/Compliance Medtronic Source Type: news

Adaptive Deep-Brain Stimulation Promising for Parkinson's Adaptive Deep-Brain Stimulation Promising for Parkinson's
Researchers test a DBS device in development that automatically senses and adjusts delivery of electrical stimulation, aiming to avoid dyskinesia and other side effects of current technology.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - June 12, 2018 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

Treatment Advances Give Hope to People with Brain Metastases
Treatment TermsMetastatic Brain and Spine Tumors Author Erin Hull Overview Lisa VanTress didn ’t know why she couldn’t regain her land legs after a 13-hour fishing trip in the summer of 2016. When the dizziness caused her to stumble and fall, she went to the emergency room. She soon learned she had lung cancer that had spread to her brain. Hero Imagebrainmets1932x862.jpg Preview Image Content Blocks CTA Header Learn More CTA ButtonBrain and Spine Metastases Patient Name Lisa VanTress Patient Photo Featured Doctors Peter E. Fecci, MD, PhD Jeffrey Melson Clarke, MD Scott R. Floyd, MD, PhD Relate...
Source: dukehealth.org: Duke Health News - June 8, 2018 Category: Consumer Health News Authors: efh7 at duke.edu Source Type: news

Adaptive deep brain stimulation for Parkinson ’s disease
Researchers designed a self-tuning deep-brain stimulation device and tested it in two patients with Parkinson ’s disease. (Source: NIH Research Matters from the National Institutes of Health (NIH))
Source: NIH Research Matters from the National Institutes of Health (NIH) - June 5, 2018 Category: Consumer Health News Source Type: news

Medical News Today: Parkinson's: 'Adaptive' brain implant may improve therapy
Deep brain stimulation is used to improve the symptoms of Parkinson's disease, but it has many limitations. Can an innovative implant avoid the drawbacks? (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 2, 2018 Category: Consumer Health News Tags: Parkinson's Disease Source Type: news

Parkinson's: 'Adaptive' brain implant may improve therapy
Deep brain stimulation is used to improve the symptoms of Parkinson's disease, but it has many limitations. Can an innovative implant avoid the drawbacks? (Source: Parkinson's Disease News From Medical News Today)
Source: Parkinson's Disease News From Medical News Today - June 2, 2018 Category: Neurology Tags: Parkinson's Disease Source Type: news

Deep brain stimulation in a rat model of post-traumatic stress disorder modifies forebrain neuronal activity and serum corticosterone - Hashtjini MM, Jahromi GP, Sadr SS, Meftahi GH, Hatef B, Javidnazar D.
OBJECTIVES: Post-traumatic stress disorder (PTSD), one of the most devastating kinds of anxiety disorders, is the consequence of a traumatic event followed by intense fear. In rats with contextual fear conditioning (CFC), a model of PTSD caused by CFC (ele... (Source: SafetyLit)
Source: SafetyLit - May 30, 2018 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news